[18F]-FDG positron imaging in clinical management of lymphoma patients. (Q34258569)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

[18F]-FDG positron imaging in clinical management of lymphoma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Corinne Haioun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

J D Rain

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Meignan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Wioland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J L Misset

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Grahek

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K Kerrou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

F Montravers

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Oncology Hematology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

193-221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

Positron Emission Tomography in Diagnosis and Therapy Monitoring of Patients with Lymphoma

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

A Perspective on Clinical PET Imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Differential diagnosis of CNS lesions in AIDS patients by FDG-PET

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Role of Fluorine-18-Fluorodeoxyglucose in the Work-up of Febrile AIDS Patients Experience with Dual Head Coincidence Imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

FDG-PET for predicting the prognosis of malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Extranodal malignant lymphoma: detection with FDG PET versus CT

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

The role of positron emission tomography (PET) in the management of lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900127-5

7 January 2021

10.1016/S1040-8428(01)00127-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11369254%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference